Clinical trials for prevention of epileptogenesis

Document Type

Conference Proceeding

Abstract

Methods to evaluate treatments that could prevent epileptogenesis in subjects at risk are described. Epilepsy prevention trials are more complex, lengthy, and costly than standard epilepsy treatment trials for many reasons. Issues revolve around selection of subjects, consent for participation, length of follow-up, and selection of an appropriate endpoint. The use of biomarkers are a possible solution in future research.

Publication Date

1-1-2006

Publication Title

Epilepsy Research

ISSN

09201211

Volume

68

Issue

1

First Page

35

Last Page

38

PubMed ID

16377141

Digital Object Identifier (DOI)

10.1016/j.eplepsyres.2005.09.015

This document is currently not available here.

Share

COinS